No adverse events were reported from patient. The pharmacy was alerted by our clinicial team via email that this patient recieved a 2nd dose of RSV. (1st dose was 1/11/2024 and 2nd dose was 1/21/2025) Patient did not need a 2nd dose of RSV Arexvy vaccine.